AIG
CYTK icon

American International Group’s Cytokinetics CYTK Stock Holding History

American International Group’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-176,072
Closed -$12.3M – 706
2024
Q1 		$12.3M Buy
176,072
+125,172
+246% +$9.68M 0.04% 321
2023
Q4 		$4.25M Sell
50,900
-335
-0.7% -$12.1K 0.02% 783
2023
Q3 		$1.51M Buy
51,235
+1,088
+2% +$36.2K 0.01% 1046
2023
Q2 		$1.64M Buy
50,147
+4,531
+10% +$168K 0.01% 1024
2023
Q1 		$1.61M Buy
45,616
+111
+0.2% +$4.53K 0.01% 1018
2022
Q4 		$2.09M Sell
45,505
-348
-0.8% -$15K 0.01% 932
2022
Q3 		$2.22M Buy
45,853
+1,109
+2% +$53.4K 0.02% 915
2022
Q2 		$1.76M Sell
44,744
-1,030
-2% -$41.5K 0.01% 978
2022
Q1 		$1.69M Sell
45,774
-2,789
-6% -$99.1K 0.01% 1081
2021
Q4 		$2.21M Sell
48,563
-1,536
-3% -$59.3K 0.01% 1030
2021
Q3 		$1.79M Buy
50,099
+5,550
+12% +$163K 0.01% 1107
2021
Q2 		$882 Sell
44,549
-35
-0.1% -$822 ﹤0.01% 1591
2021
Q1 		$1.04K Sell
44,584
-513
-1% -$11K ﹤0.01% 1437
2020
Q4 		$937 Sell
45,097
-1,093
-2% -$20K ﹤0.01% 1423
2020
Q3 		$1M Buy
46,190
+6,267
+16% +$147K ﹤0.01% 1246
2020
Q2 		$941K Buy
39,923
+1,302
+3% +$24.4K ﹤0.01% 1257
2020
Q1 		$455K Sell
38,621
-1,903
-5% -$24.3K ﹤0.01% 1480
2019
Q4 		$430K Sell
40,524
-1,084
-3% -$11.1K ﹤0.01% 1771
2019
Q3 		$473K Buy
41,608
+213
+0.5% +$2.67K ﹤0.01% 1691
2019
Q2 		$466K Buy
41,395
+5,627
+16% +$54.3K ﹤0.01% 1742
2019
Q1 		$289K Sell
35,768
-944
-3% -$6.94K ﹤0.01% 2004
2018
Q4 		$232K Sell
36,712
-447
-1% -$3.28K ﹤0.01% 2097
2018
Q3 		$366K Buy
37,159
+1,144
+3% +$9.18K ﹤0.01% 2065
2018
Q2 		$299K Buy
36,015
+9,459
+36% +$78.7K ﹤0.01% 2135
2018
Q1 		$191K Sell
26,556
-7,579
-22% -$65K ﹤0.01% 2291
2017
Q4 		$278K Buy
34,135
+159
+0.5% +$1.8K ﹤0.01% 2116
2017
Q3 		$493K Buy
33,976
+2,265
+7% +$30.9K ﹤0.01% 1773
2017
Q2 		$384K Buy
31,711
+10,859
+52% +$151K ﹤0.01% 1879
2017
Q1 		$268K Buy
20,852
+1,380
+7% +$16.1K ﹤0.01% 1992
2016
Q4 		$237K Sell
19,472
-51
-0.3% -$541 ﹤0.01% 2078
2016
Q3 		$179K Buy
19,523
+29
+0.1% +$303 ﹤0.01% 2244
2016
Q2 		$185K Sell
19,494
-1,546
-7% -$12.7K ﹤0.01% 2179
2016
Q1 		$148K Hold
21,040
– – ﹤0.01% 3058
2015
Q4 		$221K Sell
21,040
-96
-0.5% -$942 ﹤0.01% 2739
2015
Q3 		$141K Sell
21,136
-476
-2% -$3.25K ﹤0.01% 3139
2015
Q2 		$145K Sell
21,612
-3,324
-13% -$21.8K ﹤0.01% 3332
2015
Q1 		$169K Buy
24,936
+3,183
+15% +$23.8K ﹤0.01% 3107
2014
Q4 		$174K Sell
21,753
-861
-4% -$3.69K ﹤0.01% 3076
2014
Q3 		$79.6K Sell
22,614
-17
-0.1% -$71 ﹤0.01% 3726
2014
Q2 		$108K Buy
22,631
+4,523
+25% +$27.6K ﹤0.01% 3525
2014
Q1 		$172K Buy
18,108
+435
+2% +$3.93K ﹤0.01% 2964
2013
Q4 		$115K Buy
17,673
+1,070
+6% +$7.03K ﹤0.01% 3236
2013
Q3 		$126K Buy
+16,603
New +$178K ﹤0.01% 3137

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

American International Group's CYTK Position: Q2 2024 in Review

American International Group sold out of Cytokinetics (CYTK) in Q2 2024, closing a stake of 176,072 shares — an estimated $12.3M sold.

American International Group first reported a position in CYTK in Q3 2013 and held it in 43 quarters. The position peaked at $12.3M in Q1 2024. 343 funds tracked by Wall St. Rank hold CYTK as of Q2 2024.

  • American International Group reported no remaining Cytokinetics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 176,072 Cytokinetics shares in Q2 2024, an estimated $12.3M.
  • American International Group first reported a position in Cytokinetics in Q3 2013 and held it in 43 quarters.
  • American International Group's Cytokinetics position peaked at $12.3M in Q1 2024.
  • 343 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.